Good, better, best. Never let it rest. 'Til your good is better and your better is best.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CETX Cemtrex Announces NASDAQ and Henry Schein as Latest SmartDesk Customers
Long Island City, NY, April 09, 2019 (GLOBE NEWSWIRE) -- - Cemtrex Inc. (Nasdaq: CETX, CETXP, CETXW), a leading global technology company, today announced that it has added NASDAQ, Inc. and Henry Schein, Inc as its latest SmartDesk Enterprise clients. Both companies have bought SmartDesks to evaluate the product for widescale use in their organizations.
NASDAQ is one the world’s most recognized companies, operating many of the world’s stock market exchanges, with over 4500 employees globally. Henry Schein is a global Fortune 500 healthcare products company with over 18,000 employees globally.
“We continue to see new interest from major enterprises in our SmartDesk as organizations look to create cutting edge workplaces. Both NASDAQ and Henry Schein represent attractive new clients for the SmartDesk with the potential for strong long term demand,” said Saagar Govil, CEO and Chairman of Cemtrex, Inc.
The Company has received demand for SmartDesks from customers in a variety of different industries and for planned uses in different applications. The Company continues to receive orders for use in financial companies, logistics companies, call centers, innovation labs, universities, engineering firms, advertising firms, software developers, and many more.
Cemtrex’s SmartDesk is poised to be the most advanced workstation on the market. A blend of futuristic hardware and groundbreaking productivity software, the SmartDesk delivers an efficient user experience in a luxurious package. With a 72-inch, high resolution multi-touch display, integrated proprietary touch and touchless gestures as well as the ability to draw and scan documents directly on the desk, wireless connectivity for full access to the cloud, and next-generation wireless charging capabilities for mobile devices, the SmartDesk is the next step in the evolution of the modern workplace.
To learn more and stay updated about SmartDesk, please visit www.smartestdesk.com.
About Cemtrex
Cemtrex, Inc. (CETX) is the manufacturer of the SmartDesk, the world’s most advanced workstation. Cemtrex is a diversified technology company that's driving innovation in a wide range of sectors, including smart technology, virtual and augmented realities, advanced electronic systems, industrial solutions, and intelligent security systems.
www.cemtrex.com
$BOXS BoxScore Brands Management Announces Distribution Deal with Pellequr LLC.
Las Vegas, NV, April 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BoxScore Brands, Inc., (BOXS), announced a distribution deal with Pellequr LLC, a Beverly Hills, CA based spa and manufacturer of CBD related skin and wellness products.
Michael Flanagan, newly appointed CEO of BoxScore Brands, stated, “Pellequr makes the best products in each category they operate. When we looked at value added niche products in the skincare category, Pellequr’s array of products was our first choice to partner with as our initial offering.”
The US Skincare market is estimated at +$17 billion and growing annually. The integration of CBD into skin care and beauty products is also proving success through customer adoption. Flanagan stated, “We will be taking what Pellequr does so well in their Beverly Hills spa and introducing to the broader US market through existing relationships. Celebrities and influencers have flocked to Pellequr simply because the products are better than anything else in the market.”
Founded in 2018, Pellequr, LLC opened a spa to modernize age-old Korean traditions to launch the newest and ultimate experience in luxury skin care. The company uses innovative techniques and detoxification from its expert technicians using proprietary products that are infused with the transformative healing powers of CBD oil. The company has developed a series of products based around CBD oil. (Instagram @pellequr)
Founded in 2007, BoxScore Brands served +300 points of sale in California and Nevada through automated frozen vending machines and reach in freezers. In April 2019, the BoxScore Brands reposition its product offerings and focus on consumer products with Cannabidiol ("CBD") and other alternative wellness products.
BoxScore Brands, Inc. will market and distribute Pellequr products globally.
ABOUT BOXSCORE™ BRANDS, INC.
BoxScore ™ Brands, Inc, headquartered in Las Vegas, NV, is a consumer products and technology company that develops, distributes, and consumer products in the United States. For more information visit https://boxscore.com/ or call (855) 558-8363 or e-mail ir@boxscore.com.
https://finance.yahoo.com/news/boxscore-brands-management-announces-distribution-205618319.html
$VTXB Vortex Brands AppointsNew Member To Board of Directors
SACRAMENTO, Calif., April 17, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Vortex Brands Co. (VTXB) announced today a key addition to the Vortex Brands Board of Directors.
CEO Todd Higley stated, "We are pleased to announce that we have added John F. Nunley III to our board. John has a degree in Electrical Engineering and holds a masters degree in Environmental Engineering. He is a Certified Energy Manager and as the former Director of the Wyoming Energy Office, he has prior experience with earlier versions of the Phase Angle Synchronization technology."
Mr. Nunley stated, "As Director of the Wyoming Energy Office, we were early adopters of the technology and placed three test units at a lumber mill in Saratoga, a railroad tie plant in Laramie and a cold storage facility in Laramie. For the duration of the test run, the consumption efficiency at all three locations was significantly improved. Specific to the cold storage plant, after the first full month of operation, the monthly power requirements had dropped so drastically that the power company in Laramie sent one of their technicians out to check the meter at the facility. They were convinced that the meter was broken and needed to be replaced. After the meter was checked, the technician came back and reported that there were no problems. The units had actually accomplished two tasks. First, it fixed the consumption efficiency problem. Second, because the real power being consumed was more efficiently used the plant required less energy. At the time, it was intriguing to think about the massive potential of the PAS technology once implemented on a large scale."
Mr. Nunley went on to say, "The company went quiet for a while as they pursued the publicly traded route and I am excited to have recently learned that they have reached the point where the technology can now be implemented on a scale that will be beneficial to the utility industry, the company itself and to the company shareholders. I'm excited about what's to come and ready to hit the ground running."
Mr. Higley finished up with, "With John's years of experience and prior experience with an early version of our product, he is passionate about helping us to bring our product to market and will begin immediately networking with key contacts that we want to include in the rollout. We'd like to officially welcome John to the team and have other key additions to our team that will be announced in the coming days."
http://vortexgreenenergy.com/improve-the-environment/
Notice Regarding Forward-Looking Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate.
Source: Vortex Brands Co.
Contact: info@vortexbrands.us
$AMHV American Hemp Ventures, Inc. (OTC: AMHV) expands Consulting and Grow Operations by 140% in Q1
AURORA, Colo., April 3, 2019 /PRNewswire/ -- American Hemp Ventures, Inc. ("AMHV") , has added over 320,000 sq. ft of greenhouse grow operations under management dedicated to seed production during the 1st quarter of 2019. The expanded grow operations represent an increase of approximately 140% over 2018-year end. Total grow operations will now include over 540,000 sq. ft of hemp greenhouses dedicated to the production of AMHV's 4 proprietary high CBD hemp seed cultivars and the associated biomass. Current grow operations are expected to yield over 100 Million seeds per year and an estimated 50,000 lbs. of high CBD biomass.
American Hemp Ventures, Inc.
AMHV's mission is to become the world's preeminent, vertically integrated "seed-to-table" hemp operation. AMHV develops hybrid hemp cultivars that are genetically designed to produce high CBD yields in a wide variety of geographies. We apply our proprietary seed feminization process to further increase crop production as much as 100%.
The Company's subsidiaries have developed deep expertise in hemp-growing techniques and have developed various proprietary hemp cultivars, as well as a proprietary process to feminize hemp seed. The company's operations are focused on sales of hemp seed, hemp bio mass and CBD distillate, a line of CBD infused retail products, as well as providing consulting services and generating royalties from consulting clients.
AMHV currently operates three primary business streams; a) LTC Farms for the growing and cultivation of Hemp for its own account using proprietary seed types, and b) HEMP Consulting Group which provides a turnkey service to farmers and investors wishing to grow Hemp on their own land, and 3) AMHV Wellness that has developed and sells topical and nutritive CBD products for consumers and pets. Our turnkey Consulting service typically generates both consulting fees and a participation revenue.
https://finance.yahoo.com/news/american-hemp-ventures-inc-otc-020400669.html
$RVIV President of Reviv3 Procare Company Discusses Business Plan and Recent Financial Results in New Interview at SmallCapVoice.com
USTIN, Texas, May 07, 2019 (GLOBE NEWSWIRE) -- Reviv3 Procare Company (RVIV), today announce that Company president Donald Starace is featured in a new audio interview at SmallCapVoice.com.
The interview can be heard at: https://www.smallcapvoice.com/5-3-19-smallcapvoice-interview-with-reviv3-procare-company-rviv/.
Starace called in to SmallCapVoice.com to discuss the Company’s premium line of hair care products made from the highest quality natural ingredients, the management team’s extensive background in the hair care market, the strong financial footing for the company and much more. Recently, the Company posted their Q3 2019 numbers. Highlights include;
Revenues increased by 28% compared to the same comparable period in 2018.
Gross profit as a percentage of revenues increased to 43% compared to 38% for the same period in 2018.
Operating Expenses for the 3 months decreased by 36% to the same comparable period in 2018.
"These numbers show why we were so excited to be speaking with SmallCapVoice.com. We are extremely optimistic about our future with the foundation we have built over the last couple of years," stated Starace. " Once again, we are thankful for the opportunity to share our story with our followers and the SmallCapVoice.com listening audience.”
About SmallCapVoice.com Inc.
SmallCapVoice.com Inc. is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks in which they are interested. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and its services, please visit http://smallcapvoice.com/blog/the-small-cap-daily-small-cap-newsletter/
About Reviv3
Reviv3 Procare Company is engaged in the manufacturing, marketing, sale and distribution of professional quality hair and skin care products under various trademarks and brands. We are committed to using the highest quality active ingredients found in nature to create professional grade products that simply work. Our products are sold in targeted markets in United States, Canada, Europe, and Asia.
$MFST Medifirst Solutions Completes Time Machine Laser Sales for Two New Markets
Freehold, NJ, May 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device and a provider of Specialty Pharmacy Drug Consulting Services and Distributor of USA Pharma CBD, is pleased to provide a laser sales update.
Medifirst Solutions is pleased to announce that a high school in Nebraska has successfully completed a test trial using the Time Machine Therapeutic Laser for sports related injuries. After extensive usage, the trial resulted in very positive results with injuries ranging from minor or serious. Working in conjunction with a Physical Therapist at the school, the medical professionals on site specifically saw substantial improvement with students with various Achilles injuries including post-surgical recovery. Satisfied with the positive results, the school purchased its first laser for sport related injuries. Commented Medifirst President Bruce J. Schoengood, “Using the laser for sports injuries and having a school purchase a unit, both opens a new market as well as continues to validate the positive results we see every day with our laser. Sports injuries are most often associated with immediate pain and swelling and we believe our laser can be a very effective tool for medical professionals treating such injuries.”
Medifirst Solutions is also pleased to announce that after an extensive and successful trial, a Florida based Obstetrician-gynecologist (OB-GYN) has purchased the Time Machine Infrared Laser. The trial feedback indicated positive results for reduced scarring after C-sections as well as positive results as related to intravaginal tissues associated with inflammation and cysts. Continued Mr. Schoengood, “We are very excited to receive positive feedback from physicians including a purchase of our laser. There are over one million C-sections every year in the US and this represents a potential whole new market for the Time Machine Laser.”
Dr. Ronald L. Rubin, Medical Director for Medifirst, commented, “I believe the Time Machine Laser is an important tool for physicians and healthcare professionals in the battle to decrease and eliminate pain in the great majority of injuries whether at home, work, car or on the playing field. I am thrilled to see my colleagues see first-hand the great results I have seen for the last several years. We will continue to work with doctors of all specialties to expand the use and cope of our therapeutic laser.”
About the Time Machine Laser
The Time Machine Laser is the only all-in-one, affordable, FDA cleared, Infrared, 810nm, 2000mW power, small, hand-held portable laser marketed for pain relief in the U.S. The Time Machine Laser, which has been extensively tested and approved by Intertek for safety and electrical standards, has the power and frequency often found in large and expensive stationary units and at a fraction of the cost. Medifirst Solutions, Inc., in response to its Premarket Notification 510(k) submission for “The Time Machine” Series Laser, received clearance from the U.S. Food and Drug Administration (“FDA”) to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. The Laser is intended for use in temporary relief of minor muscle and joint pain, stiffness, minor arthritis pain, muscle spasm, temporary increase in local blood circulation and temporary relaxation of muscles by means of topical elevated tissue temperature from infrared spectral emissions. Visit www.medifirstsolutions.com for more information. Follow on Twitter @Medi_First and for Facebook visit Medifirst Solutions.
$BOXS BoxScore Brands Management Announces Distribution Deal with Pellequr LLC.
Las Vegas, NV, April 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BoxScore Brands, Inc., (BOXS), announced a distribution deal with Pellequr LLC, a Beverly Hills, CA based spa and manufacturer of CBD related skin and wellness products.
Michael Flanagan, newly appointed CEO of BoxScore Brands, stated, “Pellequr makes the best products in each category they operate. When we looked at value added niche products in the skincare category, Pellequr’s array of products was our first choice to partner with as our initial offering.”
The US Skincare market is estimated at +$17 billion and growing annually. The integration of CBD into skin care and beauty products is also proving success through customer adoption. Flanagan stated, “We will be taking what Pellequr does so well in their Beverly Hills spa and introducing to the broader US market through existing relationships. Celebrities and influencers have flocked to Pellequr simply because the products are better than anything else in the market.”
Founded in 2018, Pellequr, LLC opened a spa to modernize age-old Korean traditions to launch the newest and ultimate experience in luxury skin care. The company uses innovative techniques and detoxification from its expert technicians using proprietary products that are infused with the transformative healing powers of CBD oil. The company has developed a series of products based around CBD oil. (Instagram @pellequr)
Founded in 2007, BoxScore Brands served +300 points of sale in California and Nevada through automated frozen vending machines and reach in freezers. In April 2019, the BoxScore Brands reposition its product offerings and focus on consumer products with Cannabidiol ("CBD") and other alternative wellness products.
BoxScore Brands, Inc. will market and distribute Pellequr products globally.
ABOUT BOXSCORE™ BRANDS, INC.
BoxScore ™ Brands, Inc, headquartered in Las Vegas, NV, is a consumer products and technology company that develops, distributes, and consumer products in the United States. For more information visit https://boxscore.com/ or call (855) 558-8363 or e-mail ir@boxscore.com.
$ETII Breaking News - Growth and Revenues Written All Over EnviroTechnologies International, Inc. (OTC: ETII)
NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- DailyOTC.com News Commentary -- Analysts have estimated the hemp-CBD market to hit 22 billion by 2022, as consumers around the world increasingly looking to CBD oils, edibles, and other products to help treat chronic pain conditions and as a potential preventative measure for muscle soreness and inflammation. Interest around cannabis stocks continues to rise as more U.S. states are moving toward legalization.
If you're looking for ways to gain exposure to the U.S. cannabis industry, EnviroTechnologies International, Inc. (ETII), a publicly traded company based in Utah who already has one foot in the Cannabis/CBD industry, could be the right choice for both short and long term investors.
The company recently announced that it was preparing to introduce new technology to licensed cannabis growers in the northwest that will help eliminate growth-impeding pathogens and stimulate harvest yields.
“What hasn’t been covered as much is the potential and existence of fungal and contaminants that are prevalent in nearly all phases of plant growth, harvest, and post-harvest product processing of hemp and cannabis,” said Gaylord Karren, ETI’s President. “Mold and fungal presence in grow rooms as well as outside grow facilities is not only dangerous but also negatively affects the plant’s growth cycle, killing large portions of the crop and leaving bacterial residue on the plants and facilities. This reduces the growth and the ultimate yield. The problem is that there is no real non-toxic solution to eliminate mold and fungal growth in grow facilities. ETI has the only real, effective, non-toxic solution to cleaning and sanitizing plant facilities.”
EnviroTechnologies International, Inc. reported estimated 2018 revenues and First Quarter equipment orders under contract.
“We expected 2018 to be, primarily, a research and development year as we completed design and technical upgrades to our proprietary and patent-pending machines that produce electrolyzed oxidative fluids (EO Equipment), used by our customers in the carpet-cleaning, agriculture, food service and other related and unrelated industries. We anticipated contracts on our new EO Machines to begin Second Quarter 2019,” said Gaylord Karren ETI’s President.
“First Quarter, 2019 revenues will be approximately $605,000 and contracts for Second Quarter, 2019 are expected to be $885,000.”
The company is in a good position to take advantage of the burgeoning Hemp/CBD Pet industry.
Last year the company confirmed that its subsidiary, CBD Health Co., (www.cbdhealthco.com), a company that markets and sells high quality and proprietary hemp-based, natural CBD health products, is progressing in its hemp-based pet supplement products development.
“Much has been written lately about CBD products and the numerous applications for humans and pets, which has raised consciousness of CBD’s therapeutic value. Our CBD products are all cannabidiol-based, which means they are not psychoactive and are safe for pets,” said Joe De Leon, CBD’s President. “When your pet gets sick, you want the best treatment available and the products we are developing will offer better, more effective and safer medicinal options for pets than traditional pet health products.”
The company (ETII) intends to work closely with veterinarian doctors attending trade shows, and launching national campaigns to penetrate the market. Along the way we will educate the public on safe and natural ways to treat their pets.
With this type of impressive growth, it's no wonder why many Investors believe that EnviroTechnologies International, Inc. (ETII) shares are undervalued.
Full Disclaimer: http://www.dailyotc.com/disclaimer/
http://www.dailyotc.com
Contact: info@dailyotc.com
$RGBP #LatestNews Regen BioPharma, Inc. Responds to Fake News Release
https://www.otcmarkets.com/stock/RGBP/news/Regen-BioPharma-Inc-Responds-to-Fake-News-Release?id=227593
$BIXT ON ALERT Bioxytran Inc. Announces Appointment of Ex Bristol-Myers Squibb Executive to Scientific Advisory Board
BOSTON, MASSACHUSETTS, May 06, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), a developmental stage biotechnology company developing a pipeline of anti-necrosis drugs designed to treat hypoxia by delivering a small molecule carrying oxygen to the brain of stroke victims announced today that it has retained Juan Carlos Lopez-Talavera, MD, PhD to join Bioxytran’s Scientific Advisory Board to manage the company’s FDA regulatory application process for Bioxytran’s flagship drug, BXT-25.
“Dr. Lopez-Talavera will play an important role in overseeing our new drug through the FDA’s regulatory process,” stated Bioxytran CEO, David Platt. “Juan has been instrumental in expediting well known drugs such as OCALIVA® through the regulatory process. We believe that Juan’s personal and professional relationships with some of the top pharmaceutical companies and Key Opinion Leaders will bring great value to Bioxytran. His experience in tissue regeneration will bring great skills to our FDA application process and designing our trials for Ischemic Stroke. Bioxytran is truly fortunate to acquire talent of such a high caliber.”
“Dr. Lopez-Talavera has a reputation of developing disruptive technologies which we believe is critical for compounds such as Bioxytran’s BXT-25. It is rare to obtain such a qualified candidate in a developmental stage company like Bioxytran, and we view it as an endorsement of our plans for BXT-25.”
Dr. Lopez-Talavera has over 20 years of experience in the biopharma industry, with extensive expertise in liver and gastrointestinal diseases. Most recently, Dr. Lopez-Talavera was Senior Vice President, Head of Medical Affairs and member of the Executive Team at Intercept Pharmaceuticals. Previously he held positions at AbbVie as Head of Medical Affairs, Global Research and Development, Bristol Myers Squibb, as Vice President and Global Development Lead, and Roche Laboratories as Senior Medical Director. Before moving into the industry, Dr. Lopez-Talavera was an Assistant Professor with the Divisions of Gastroenterology and Hepatology, and Endocrinology and Pathology at the University of Pittsburgh Medical Center, Associate Professor of Medicine with the Universidad Autónoma de Barcelona and Attending Physician of the Liver Unit at the Hospital General Universitari Vall D’Hebron in Barcelona.
“In my professional career I have always gravitated toward working with novel mechanisms. “ said Dr. Lopez-Talavera. ”The opportunity at Bioxytran is so vast, because tissue oxygenation represents a true unmet medical need and represents a tremendous untapped opportunity to target both the Ischemic Stroke and, has future potential for Acute Respiratory Distress Syndrome (“ARDS”). BXT-25 has the unique ability to deliver oxygen through a small molecule which can be effective in extending the “golden hour” in stroke victims and potentially for tissue regeneration in ARDS victims. I am honored to be part of this team and look forward to advancing the science and creating partnerships or joint ventures that will grow this field of research.”
Dr. Lopez-Talavera was a Postdoctoral Fellow at the Yale University School of Medicine, and Clinical Observer at Sloan Kettering Memorial Cancer Center. He holds an M.D. and a Ph.D. in Hepatology from the Universidad Autónoma de Barcelona.
About Bioxytran, Inc.
Bioxytran Inc. is a developmental stage biotechnology company. The company is working towards a first-in-class oxygen treatment platform for victims of brain stroke trauma. The first product to proceed to testing is BXT-25, which will be evaluated as a resuscitative agent to treat strokes, especially during the all-critical first hour following a stroke. The product will also be evaluated for its efficacy in treating other brain trauma issues. BXT-25 is based on a new molecule designed to reverse hypoxia in the brain. Hypoxic brain injuries such as ischemic strokes, could be treated with BXT-25 via an intravenous injection that quickly allows the drug molecule to travel to the lungs and bind with the oxygen molecules. From the lungs the molecule mimics a red blood cell traveling to the brain. Since the molecule is 5,000 times smaller than red blood cells it can penetrate the clot and deliver the oxygen to the critical areas in the brain blocked by the clot. To learn more, visit our website: http://www.Bioxytraninc.com
$RVIV Reviv3 Procare Company Appoints Heather Cornell as Director of Investor Relations
LOS ANGELES, California, May 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Reviv3 Procare Company (RVIV) announced today that Ms. Heather Cornell has joined the company as Director of Investor Relations. Ms. Cornell will lead Reviv3’s corporate communication of its strategies, corporate initiatives and roadmap to analysts and investors. Ms. Cornell has over 20 years of experience in communications, strategic marketing and leading presentations at conferences and corporate events.
“Heather brings a strong set of competencies to Reviv3 as we continue to enhance our communication and corporate relationship with the investment community and we are excited to have her join our team,” said Donald Starace, President of Reviv3. “Her addition to Reviv3 allows us to effectively share our company outlook and shareholder value proposition.”
Ms. Cornell commented, “I look forward to contributing my expertise in corporate engagement and communication to Reviv3 during this remarkable period for the company. I will work to proactively anticipate and address investor focus areas and maintain a strong relationship of trust and respect with the investor community.”
About Reviv3 Procare Company
Reviv3 Procare Company is engaged in the manufacturing, marketing, sales, and distribution of professional quality hair and skin care products under various trademarks and brands. We are committed to using the highest quality active ingredients found in nature to create professional grade products that simply work. Our products are sold in targeted markets in the United States, Canada, Europe, and Asia.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. The use of words such as “anticipates,” “expects,” “intends,” “plans,” “confident that” and “believes,” among others, generally identify as forward-looking statements.
These forward-looking statements are based on currently available information, management’s beliefs, future projections, and current expectations subject to a number of significant risks and uncertainties. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: (i) Reviv3’s ability to grow net sales and adjusted EBITDA as anticipated (ii) our ability to fund our operating expenses (iii) potential difficulties or delays Reviv3 may experience in implementing its cost savings and efficiency initiatives; (iv) Reviv3’s ability to compete effectively with other hair and skin care companies (v) the concentration of Reviv3’s customers, potentially increasing the negative impact to Reviv3 by changing purchasing or selling patterns (vi) changes in laws or regulations in the United States and/or in other major markets, such as China, in which Reviv3 operates, including, without limitation, with respect to taxes, tariffs, trade policies or product safety, which may increase Reviv3’s product costs and other costs of doing business, and reduce Reviv3’s earnings. Potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. These forward-looking statements speak only as of the date hereof. Except as required by law, Reviv3 does not assume any obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.
Heather Cornell
888-638-8883
ir@reviv3.com
https://finance.yahoo.com/news/reviv3-procare-company-appoints-heather-120000671.html
$MFST #BreakingNews Medifirst Solutions Completes Time Machine Laser Sales for Two New Markets
Freehold, NJ, May 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device and a provider of Specialty Pharmacy Drug Consulting Services and Distributor of USA Pharma CBD, is pleased to provide a laser sales update.
Medifirst Solutions is pleased to announce that a high school in Nebraska has successfully completed a test trial using the Time Machine Therapeutic Laser for sports related injuries. After extensive usage, the trial resulted in very positive results with injuries ranging from minor or serious. Working in conjunction with a Physical Therapist at the school, the medical professionals on site specifically saw substantial improvement with students with various Achilles injuries including post-surgical recovery. Satisfied with the positive results, the school purchased its first laser for sport related injuries. Commented Medifirst President Bruce J. Schoengood, “Using the laser for sports injuries and having a school purchase a unit, both opens a new market as well as continues to validate the positive results we see every day with our laser. Sports injuries are most often associated with immediate pain and swelling and we believe our laser can be a very effective tool for medical professionals treating such injuries.”
Medifirst Solutions is also pleased to announce that after an extensive and successful trial, a Florida based Obstetrician-gynecologist (OB-GYN) has purchased the Time Machine Infrared Laser. The trial feedback indicated positive results for reduced scarring after C-sections as well as positive results as related to intravaginal tissues associated with inflammation and cysts. Continued Mr. Schoengood, “We are very excited to receive positive feedback from physicians including a purchase of our laser. There are over one million C-sections every year in the US and this represents a potential whole new market for the Time Machine Laser.”
Dr. Ronald L. Rubin, Medical Director for Medifirst, commented, “I believe the Time Machine Laser is an important tool for physicians and healthcare professionals in the battle to decrease and eliminate pain in the great majority of injuries whether at home, work, car or on the playing field. I am thrilled to see my colleagues see first-hand the great results I have seen for the last several years. We will continue to work with doctors of all specialties to expand the use and cope of our therapeutic laser.”
About the Time Machine Laser
The Time Machine Laser is the only all-in-one, affordable, FDA cleared, Infrared, 810nm, 2000mW power, small, hand-held portable laser marketed for pain relief in the U.S. The Time Machine Laser, which has been extensively tested and approved by Intertek for safety and electrical standards, has the power and frequency often found in large and expensive stationary units and at a fraction of the cost. Medifirst Solutions, Inc., in response to its Premarket Notification 510(k) submission for “The Time Machine” Series Laser, received clearance from the U.S. Food and Drug Administration (“FDA”) to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. The Laser is intended for use in temporary relief of minor muscle and joint pain, stiffness, minor arthritis pain, muscle spasm, temporary increase in local blood circulation and temporary relaxation of muscles by means of topical elevated tissue temperature from infrared spectral emissions. Visit www.medifirstsolutions.com for more information. Follow on Twitter @Medi_First and for Facebook visit Medifirst Solutions.
$BIXT Bioxytran Inc. Announces Appointment of Ex Bristol-Myers Squibb Executive to Scientific Advisory Board
https://finance.yahoo.com/news/bioxytran-inc-announces-appointment-ex-110826145.html
$BOXS CBD Wellness Space Filling up Fast: More Cannabis Companies Adjust 2019 Strategies
Point Roberts, Washington and Delta, British Columbia--(Newsfile Corp. - April 22, 2019) - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks and BoxScore Brands release a cannabis sector snapshot featuring BoxScore Brands, Inc. (OTC: BOXS) that looks at the continued mad rush to enter into the CBD wellness arena from cannabis companies of all sizes, as many see this as a massive potential revenue earner for 2019.
According to New Frontier Data and MJ Freeway, the top-three reasons why consumers use cannabis are; for relaxation (66%), stress relief (59%) and to reduce anxiety (53%). Other reasons include improving sleep, treatment of medical conditions and to enjoy social experiences. These reasons as well as the media hype surrounding CBD are driving many to change their strategic positions and invest more in the wellness segment of CBD.
BoxScore Brands, Inc., (OTC: BOXS), a company that develops, markets, and distributes cannabis related and other alternative wellness products, including ice cream electronic kiosks in North America, recently announced the addition of consumer goods industry veteran Michael P. Flanagan. The Company is also announcing a new strategic direction focused on opportunities within CBD and other alternative wellness products.
Michael Flanagan, newly appointed CEO of BoxScore Brands stated, "Cannabis and other alternative wellness products today resemble the tech industry 25 years ago. The opportunities are broad and consumer adoption is expanding rapidly. We currently operate in California and Nevada, two states at the forefront of adoption and demonstrable growth. This makes perfect sense for the company to pivot product offerings given the positive regulatory environment and our existing assets."
Read full article:
https://www.investorideas.com//News/2019/cannabis/04221CBDWellness-2019Strategies.asp
ABOUT BOXSCORE™ BRANDS, INC.
BoxScore ™ Brands, Inc, headquartered in Orange, CA, and with offices in Orange, CA and Las Vegas, NV, is a consumer products and technology company that develops, distributes, and retails specialty foods across North America. For more information visit www.boxscore.com
For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
About Investorideas.com - News that Inspires Big Investing Ideas
https://www.investorideas.com/About/
Investorideas.com is a recognized news source publishing third party news and press releases, plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts, articles, podcasts and videos talking about cannabis, crypto, technology including AI and IoT, mining, sports, biotech, water, renewable energy and more. Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Forward Looking Statements: This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports.
$DSCR #BreakingNews DSCR Announces Mining Operations Will Commence Late June 2019 on War Eagle Mountain
Mining Operations on War Eagle Mountain will Commence late June on a near surface section of the Oro Fino Trench
Phoenix, AZ, May 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Discovery Minerals LTD (DSCR) is an acquisition and development Company that targets natural resource properties primarily in precious metals and mining operations. Discovery Minerals is pleased to announce that mining operations will commence on the War Eagle Mountain Project in late June, 2019 on the Oro Fino Trench.
As previously reported the initial mining target is a near surface extension of the Oro Fino Vein with approximately 70,000 tons of ore. The recent independent survey by Geoff Boswell of Underhill Associates revised the ore grade from 10g per ton to 15g per ton Gold with a ratio of 5 oz of Silver for each oz of Gold. It is also expected to find enrichment cross structures with greater tonnages in the dilation zone and higher grades of gold & silver at these intersections. While this initial operation is progressing the Company expects to encounter further ore positions while mining development headings to expand operations. To be clear this is only a small fraction of the War Eagle Mountain Project and the Company’s planned operations. Oro Fino is one of three vein structures that have shafts to a 1250 feet depth and can be traced for 2 miles. The other two significant structures being Central and Poorman.
Russell Smith, CEO of Discovery Minerals, Ltd, stated, “The Company and their JV partner are enjoying the prospect of the commencement of a serious mining campaign on this prolifically productive and well regarded historic mining area, situated in the Owyhee Gold area of the Silver City Mining District. We have a tremendous team in place and look forward to reporting on continued progress as we identify additional target ore bodies. All Geologists, including the most recent conclusions of Underhill Associates, state that War Eagle Mountain contains multiple high grade gold and silver veins, similar to those of the rich mines of northern Nevada and we look forward to many years of operations to fully develop this resource. This is both the culmination of many previous years of work and the beginning of an extremely exciting time for the Company and our Shareholders. As always I would like to thank our Shareholders for their continued support as we grow Discovery Minerals.”
About Discovery Minerals Ltd.:
Discovery Minerals Ltd. (OTC PINK : DSCR) is an acquisition and development company that targets natural resource properties and cutting edge technology opportunities through its subsidiaries. The Board of Directors has determined that these activities be continued with an emphasis on early positive cash flow from any projects undertaken.
History of War Eagle Mountain.
War Eagle Mountain is a proven historic gold and silver resource located within the Silver City Mining District in Owyhee County, Idaho. The Oro Fino Vein was discovered in 1862 and extends approximately 12,500 feet in length and 2,000 feet in depth producing about 415,000 ounces of gold through 1875. During the fall and winter of 1874 the owners of the Golden Chariot mine completely refurbished the shaft and mill equipment, effectively "betting the ranch" on the secure knowledge that the Oro Fino Vein continued uninterrupted for a considerable distance and that approximately 85 % of the "known" and "mapped" veins had not yet been mined. By the end of 1875 a total of ten shafts had been sunk on the vein ranging in depth from 300 feet to 1250 . At the height of the mining boom on the Oro Fino Vein, there was a nationwide depression with Bank collapses and the source of working capital for the mines dried up. During the winter of 1875-1876 the shafts filled with water to a point that the Golden Chariot Shaft contained 1100 feet of standing water. In 1904 the American Smelter Corporation drove the Sinker tunnel to drain the mine, however production mining never commenced before the tunnel entrance was covered in a landslide. This cloistered condition has existed for the past 140 years, which has resulted in the preservation of this historical vein system without it being disturbed by intruders or miners. The Sinker Tunnel was rediscovered in 1994 and current ownership has been assembling the patented claims for years finally bringing the Sinker Tunnel, Patented Claims and a modern Mill under common control to allow mining operations to resume. The early mining at this historic resource was accomplished primarily with picks and shovels and a few pounds of black powder. Now with modern equipment and techniques the DSCR JV will seek to mine the balance of the War Eagle Mountain hydrothermal deposits. Mining will include the Oro Fino, Poorman and Central vein systems.
https://finance.yahoo.com/news/dscr-announces-mining-operations-commence-123000872.html
$RVIV announce that Company president Donald Starace is featured in a new audio interview at SmallCapVoice.com.
The interview can be heard at: https://www.smallcapvoice.com/5-3-19-smallcapvoice-interview-with-reviv3-procare-company-rviv/
$ADHC American Diversified Holdings Corporation's Cannabis Division Chosen To Be The Presenting Sponsor of the Seattle Hempfest, The World's Largest Hemp Festival
https://finance.yahoo.com/news/american-diversified-holdings-corporations-cannabis-120000065.html
$DSCR Announces Site Survey Update for War Eagle Mountain Mining Plan
https://www.bloomberg.com/press-releases/2019-05-02/dscr-announces-site-survey-update-for-war-eagle-mountain-mining-plan
$ADHC American Diversified Holdings Corporation's Cannabis Division Chosen To Be The Presenting Sponsor of the Seattle Hempfest, The World's Largest Hemp Festival
DEL MAR, CA / ACCESSWIRE / May 7, 2019 / American Diversified Holdings Corporation's (OTC PINK: "ADHC") COO, Liam Riley announced today that the company has been chosen to become the 2019 presenting sponsor of the world's largest cannabis festival; The 2019 Hempfest, Seattle. The event will take place August 16-18, 2019 in Seattle Wa.
"We are honored to be chosen for such a presitigious sponsorship position", commented Liam Riley ADHC's COO. "We have been working diligently to assemble a concrete seed to sale business plan. Obviously, the visibility of our involvement with Seattle Hempfest is invaluable to building our brand both in terms of our business initiatives and for our shareholders," concluded Mr. Riley.
"Seattle Hempfest is excited to have American Diversified Holdings Corporation as our presenting sponsor as we promote our mutual interests and our shared vision of a thriving legal cannabis industry and culture," says Seattle Hempfest's executive director, Vivian McPeak.
ABOUT SEATTLE HEMPFEST. www.HEMPFEST.org
Seattle HEMPFEST, the undisputed King of Protestivals, and the largest cannabis convocation in the world.
Seattle HEMPFEST, the premier flagship event of the global cannabis culture, is celebrating its 28th year. Hempfest's crown jewels of achievement include its designation as the largest annual cannabis policy reform event in the world. Seattle HEMPFEST is the most sophisticated and socially responsible cannabis rally in history, and perhaps the largest annual free speech event in the nation. Hempfest 2019 Aug 16, 17, 18 hours are Fri Noon - 8PM, Sat/Sun 10AM - 8PM.
With a laser focus on political content and a deep commitment to community values, Seattle's HEMPFEST event has influenced regional and national public policy while being an economic generator in its community. Seattle's HEMPFEST event paved the way and tilled the soil for Washington State citizens to legalize cannabis before any other state
The Seattle HEMPFEST enters its 28th year with a volunteer event staff of 800, and operating 4 stages of non-stop speakers and music & 400 arts, crafts, food, and informational vendors.
No other cannabis event can boast the extensive speaker's list of Seattle HEMPFEST. Seattle's current and former mayors have spoken from HEMPFEST's Main Stage, along with U.S. Congressman Dana Rohrabacher, former U.S. Congressman Dennis Kucinich, former Seattle Police Chief Norm Stamper, actor Woody Harrelson, and a cadre of notable reform movement luminaries and celebrities.
Our huge Ric Smith Memorial Hemposium tent features press conferences, panel discussions, and keynote speakers during the free 3 day waterfront event.
Established in 1991, the Seattle HEMPFEST rally features 100 music acts on four stages and an equal number of renowned guest speakers. As many as 400 arts, crafts, food, and political vendors dot the long expanse of both parks. The Seattle HEMPFEST event has a "Hemposium" circus tent replete with panel discussions and presentations, keynote speakers, displays, and workshops. The HEMPFEST "protestival" requires over 118 crews staffed by volunteers. The largest cannabis policy reform event in the world, the Seattle Hempfest event always happens the third weekend in the month of August.
The world's largest annual cannabis reform protestival exists to remind that, despite the reforms that have happened in multiple states, cannabis remains federally illegal. With thousands of Americans still in jails and prisons over cannabis the need for activism, advocacy, and political speech around the issues of cannabis reform is still as urgent as it has ever been. Seattle Hempfest will feature over a hundred bands and speakers from the cannabis industry, culture, and reform movement, as well as daily panel discussions on a variety of topics, and 300+ commercial vendors.
Information about Seattle Hempfest on a variety of topics, including history, platform, past participants, and trademark usage can be found on the Seattle Hempfest Media Page at:
https://www.hempfest.org/festival/media/
About Bloomberg Edelson, LLC
Bloomberg Edelson LLC is a boutique marketing & consulting firm located in the Seattle Metro Area. The firm is known for its "Innovative Cannabis Branding" strategies by creating living brands that are engaging and responsive. Members of the firm's advisory team have lived, breathed and thrived in the Cannabis/Hemp/CBD marketplace for 15 years.
$BIXT News: Bioxytran Inc. Announces Appointment of Ex Bristol-Myers Squibb Executive to Scientific Advisory Board
https://finance.yahoo.com/news/bioxytran-inc-announces-appointment-ex-110826145.html … @frontpagestocks
$BIXT Bioxytran Inc. Announces Appointment of Ex Bristol-Myers Squibb Executive to Scientific Advisory Board
https://finance.yahoo.com/news/bioxytran-inc-announces-appointment-ex-110826145.html
$BOXS BoxScore Brands Management Announces Distribution Deal with Pellequr LLC.
https://www.bloomberg.com/press-releases/2019-04-30/boxscore-brands-management-announces-distribution-deal-with-pellequr-llc
$ADHC #News American Diversified Holdings Corporation's Cannabis Division Chosen To Be The Presenting Sponsor of the Seattle Hempfest, The World's Largest Hemp Festival
https://finance.yahoo.com/news/american-diversified-holdings-corporations-cannabis-120000065.html
$ADHC #NewsToday American Diversified Holdings Corporation's Cannabis Division Chosen To Be The Presenting Sponsor of the Seattle Hempfest, The World's Largest Hemp Festival
DEL MAR, CA / ACCESSWIRE / May 7, 2019 / American Diversified Holdings Corporation's (OTC PINK: "ADHC") COO, Liam Riley announced today that the company has been chosen to become the 2019 presenting sponsor of the world's largest cannabis festival; The 2019 Hempfest, Seattle. The event will take place August 16-18, 2019 in Seattle Wa.
"We are honored to be chosen for such a presitigious sponsorship position", commented Liam Riley ADHC's COO. "We have been working diligently to assemble a concrete seed to sale business plan. Obviously, the visibility of our involvement with Seattle Hempfest is invaluable to building our brand both in terms of our business initiatives and for our shareholders," concluded Mr. Riley.
"Seattle Hempfest is excited to have American Diversified Holdings Corporation as our presenting sponsor as we promote our mutual interests and our shared vision of a thriving legal cannabis industry and culture," says Seattle Hempfest's executive director, Vivian McPeak.
ABOUT SEATTLE HEMPFEST. www.HEMPFEST.org
Seattle HEMPFEST, the undisputed King of Protestivals, and the largest cannabis convocation in the world.
Seattle HEMPFEST, the premier flagship event of the global cannabis culture, is celebrating its 28th year. Hempfest's crown jewels of achievement include its designation as the largest annual cannabis policy reform event in the world. Seattle HEMPFEST is the most sophisticated and socially responsible cannabis rally in history, and perhaps the largest annual free speech event in the nation. Hempfest 2019 Aug 16, 17, 18 hours are Fri Noon - 8PM, Sat/Sun 10AM - 8PM.
With a laser focus on political content and a deep commitment to community values, Seattle's HEMPFEST event has influenced regional and national public policy while being an economic generator in its community. Seattle's HEMPFEST event paved the way and tilled the soil for Washington State citizens to legalize cannabis before any other state
The Seattle HEMPFEST enters its 28th year with a volunteer event staff of 800, and operating 4 stages of non-stop speakers and music & 400 arts, crafts, food, and informational vendors.
No other cannabis event can boast the extensive speaker's list of Seattle HEMPFEST. Seattle's current and former mayors have spoken from HEMPFEST's Main Stage, along with U.S. Congressman Dana Rohrabacher, former U.S. Congressman Dennis Kucinich, former Seattle Police Chief Norm Stamper, actor Woody Harrelson, and a cadre of notable reform movement luminaries and celebrities.
Our huge Ric Smith Memorial Hemposium tent features press conferences, panel discussions, and keynote speakers during the free 3 day waterfront event.
Established in 1991, the Seattle HEMPFEST rally features 100 music acts on four stages and an equal number of renowned guest speakers. As many as 400 arts, crafts, food, and political vendors dot the long expanse of both parks. The Seattle HEMPFEST event has a "Hemposium" circus tent replete with panel discussions and presentations, keynote speakers, displays, and workshops. The HEMPFEST "protestival" requires over 118 crews staffed by volunteers. The largest cannabis policy reform event in the world, the Seattle Hempfest event always happens the third weekend in the month of August.
The world's largest annual cannabis reform protestival exists to remind that, despite the reforms that have happened in multiple states, cannabis remains federally illegal. With thousands of Americans still in jails and prisons over cannabis the need for activism, advocacy, and political speech around the issues of cannabis reform is still as urgent as it has ever been. Seattle Hempfest will feature over a hundred bands and speakers from the cannabis industry, culture, and reform movement, as well as daily panel discussions on a variety of topics, and 300+ commercial vendors.
Information about Seattle Hempfest on a variety of topics, including history, platform, past participants, and trademark usage can be found on the Seattle Hempfest Media Page at:
https://www.hempfest.org/festival/media/
About Bloomberg Edelson, LLC
Bloomberg Edelson LLC is a boutique marketing & consulting firm located in the Seattle Metro Area. The firm is known for its "Innovative Cannabis Branding" strategies by creating living brands that are engaging and responsive. Members of the firm's advisory team have lived, breathed and thrived in the Cannabis/Hemp/CBD marketplace for 15 years.
https://finance.yahoo.com/news/american-diversified-holdings-corporations-cannabis-120000065.html
$ADHC #NewsToday American Diversified Holdings Corporation's Cannabis Division Chosen To Be The Presenting Sponsor of the Seattle Hempfest, The World's Largest Hemp Festival
DEL MAR, CA / ACCESSWIRE / May 7, 2019 / American Diversified Holdings Corporation's (OTC PINK: "ADHC") COO, Liam Riley announced today that the company has been chosen to become the 2019 presenting sponsor of the world's largest cannabis festival; The 2019 Hempfest, Seattle. The event will take place August 16-18, 2019 in Seattle Wa.
"We are honored to be chosen for such a presitigious sponsorship position", commented Liam Riley ADHC's COO. "We have been working diligently to assemble a concrete seed to sale business plan. Obviously, the visibility of our involvement with Seattle Hempfest is invaluable to building our brand both in terms of our business initiatives and for our shareholders," concluded Mr. Riley.
"Seattle Hempfest is excited to have American Diversified Holdings Corporation as our presenting sponsor as we promote our mutual interests and our shared vision of a thriving legal cannabis industry and culture," says Seattle Hempfest's executive director, Vivian McPeak.
ABOUT SEATTLE HEMPFEST. www.HEMPFEST.org
Seattle HEMPFEST, the undisputed King of Protestivals, and the largest cannabis convocation in the world.
Seattle HEMPFEST, the premier flagship event of the global cannabis culture, is celebrating its 28th year. Hempfest's crown jewels of achievement include its designation as the largest annual cannabis policy reform event in the world. Seattle HEMPFEST is the most sophisticated and socially responsible cannabis rally in history, and perhaps the largest annual free speech event in the nation. Hempfest 2019 Aug 16, 17, 18 hours are Fri Noon - 8PM, Sat/Sun 10AM - 8PM.
With a laser focus on political content and a deep commitment to community values, Seattle's HEMPFEST event has influenced regional and national public policy while being an economic generator in its community. Seattle's HEMPFEST event paved the way and tilled the soil for Washington State citizens to legalize cannabis before any other state
The Seattle HEMPFEST enters its 28th year with a volunteer event staff of 800, and operating 4 stages of non-stop speakers and music & 400 arts, crafts, food, and informational vendors.
No other cannabis event can boast the extensive speaker's list of Seattle HEMPFEST. Seattle's current and former mayors have spoken from HEMPFEST's Main Stage, along with U.S. Congressman Dana Rohrabacher, former U.S. Congressman Dennis Kucinich, former Seattle Police Chief Norm Stamper, actor Woody Harrelson, and a cadre of notable reform movement luminaries and celebrities.
Our huge Ric Smith Memorial Hemposium tent features press conferences, panel discussions, and keynote speakers during the free 3 day waterfront event.
Established in 1991, the Seattle HEMPFEST rally features 100 music acts on four stages and an equal number of renowned guest speakers. As many as 400 arts, crafts, food, and political vendors dot the long expanse of both parks. The Seattle HEMPFEST event has a "Hemposium" circus tent replete with panel discussions and presentations, keynote speakers, displays, and workshops. The HEMPFEST "protestival" requires over 118 crews staffed by volunteers. The largest cannabis policy reform event in the world, the Seattle Hempfest event always happens the third weekend in the month of August.
The world's largest annual cannabis reform protestival exists to remind that, despite the reforms that have happened in multiple states, cannabis remains federally illegal. With thousands of Americans still in jails and prisons over cannabis the need for activism, advocacy, and political speech around the issues of cannabis reform is still as urgent as it has ever been. Seattle Hempfest will feature over a hundred bands and speakers from the cannabis industry, culture, and reform movement, as well as daily panel discussions on a variety of topics, and 300+ commercial vendors.
Information about Seattle Hempfest on a variety of topics, including history, platform, past participants, and trademark usage can be found on the Seattle Hempfest Media Page at:
https://www.hempfest.org/festival/media/
About Bloomberg Edelson, LLC
Bloomberg Edelson LLC is a boutique marketing & consulting firm located in the Seattle Metro Area. The firm is known for its "Innovative Cannabis Branding" strategies by creating living brands that are engaging and responsive. Members of the firm's advisory team have lived, breathed and thrived in the Cannabis/Hemp/CBD marketplace for 15 years.
https://finance.yahoo.com/news/american-diversified-holdings-corporations-cannabis-120000065.html
$ADHC #NewsToday American Diversified Holdings Corporation's Cannabis Division Chosen To Be The Presenting Sponsor of the Seattle Hempfest, The World's Largest Hemp Festival
DEL MAR, CA / ACCESSWIRE / May 7, 2019 / American Diversified Holdings Corporation's (OTC PINK: "ADHC") COO, Liam Riley announced today that the company has been chosen to become the 2019 presenting sponsor of the world's largest cannabis festival; The 2019 Hempfest, Seattle. The event will take place August 16-18, 2019 in Seattle Wa.
"We are honored to be chosen for such a presitigious sponsorship position", commented Liam Riley ADHC's COO. "We have been working diligently to assemble a concrete seed to sale business plan. Obviously, the visibility of our involvement with Seattle Hempfest is invaluable to building our brand both in terms of our business initiatives and for our shareholders," concluded Mr. Riley.
"Seattle Hempfest is excited to have American Diversified Holdings Corporation as our presenting sponsor as we promote our mutual interests and our shared vision of a thriving legal cannabis industry and culture," says Seattle Hempfest's executive director, Vivian McPeak.
ABOUT SEATTLE HEMPFEST. www.HEMPFEST.org
Seattle HEMPFEST, the undisputed King of Protestivals, and the largest cannabis convocation in the world.
Seattle HEMPFEST, the premier flagship event of the global cannabis culture, is celebrating its 28th year. Hempfest's crown jewels of achievement include its designation as the largest annual cannabis policy reform event in the world. Seattle HEMPFEST is the most sophisticated and socially responsible cannabis rally in history, and perhaps the largest annual free speech event in the nation. Hempfest 2019 Aug 16, 17, 18 hours are Fri Noon - 8PM, Sat/Sun 10AM - 8PM.
With a laser focus on political content and a deep commitment to community values, Seattle's HEMPFEST event has influenced regional and national public policy while being an economic generator in its community. Seattle's HEMPFEST event paved the way and tilled the soil for Washington State citizens to legalize cannabis before any other state
The Seattle HEMPFEST enters its 28th year with a volunteer event staff of 800, and operating 4 stages of non-stop speakers and music & 400 arts, crafts, food, and informational vendors.
No other cannabis event can boast the extensive speaker's list of Seattle HEMPFEST. Seattle's current and former mayors have spoken from HEMPFEST's Main Stage, along with U.S. Congressman Dana Rohrabacher, former U.S. Congressman Dennis Kucinich, former Seattle Police Chief Norm Stamper, actor Woody Harrelson, and a cadre of notable reform movement luminaries and celebrities.
Our huge Ric Smith Memorial Hemposium tent features press conferences, panel discussions, and keynote speakers during the free 3 day waterfront event.
Established in 1991, the Seattle HEMPFEST rally features 100 music acts on four stages and an equal number of renowned guest speakers. As many as 400 arts, crafts, food, and political vendors dot the long expanse of both parks. The Seattle HEMPFEST event has a "Hemposium" circus tent replete with panel discussions and presentations, keynote speakers, displays, and workshops. The HEMPFEST "protestival" requires over 118 crews staffed by volunteers. The largest cannabis policy reform event in the world, the Seattle Hempfest event always happens the third weekend in the month of August.
The world's largest annual cannabis reform protestival exists to remind that, despite the reforms that have happened in multiple states, cannabis remains federally illegal. With thousands of Americans still in jails and prisons over cannabis the need for activism, advocacy, and political speech around the issues of cannabis reform is still as urgent as it has ever been. Seattle Hempfest will feature over a hundred bands and speakers from the cannabis industry, culture, and reform movement, as well as daily panel discussions on a variety of topics, and 300+ commercial vendors.
Information about Seattle Hempfest on a variety of topics, including history, platform, past participants, and trademark usage can be found on the Seattle Hempfest Media Page at:
https://www.hempfest.org/festival/media/
About Bloomberg Edelson, LLC
Bloomberg Edelson LLC is a boutique marketing & consulting firm located in the Seattle Metro Area. The firm is known for its "Innovative Cannabis Branding" strategies by creating living brands that are engaging and responsive. Members of the firm's advisory team have lived, breathed and thrived in the Cannabis/Hemp/CBD marketplace for 15 years.
https://finance.yahoo.com/news/american-diversified-holdings-corporations-cannabis-120000065.html
$RVIV , today announce that Company president Donald Starace is featured in a new audio interview at SmallCapVoice.com.
The interview can be heard at: https://www.smallcapvoice.com/5-3-19-smallcapvoice-interview-with-reviv3-procare-company-rviv/.
$DSCR Announces Site Survey Update for War Eagle Mountain Mining Plan
https://www.bloomberg.com/press-releases/2019-05-02/dscr-announces-site-survey-update-for-war-eagle-mountain-mining-plan
$RVIV ON ALERT ! @ReviveProcare Reviv3 Procare Company Reports Third Quarter 2019 Financial Results 3rd Quarter Highlights: Revenues increased by 28% Gross profit increased 43%
https://www.globenewswire.com/news-release/2019/04/10/1802373/0/en/Reviv3-Procare-Company-Reports-Third-Quarter-2019-Financial-Results.html
$RVIV ON ALERT ! @ReviveProcare Reviv3 Procare Company Reports Third Quarter 2019 Financial Results 3rd Quarter Highlights: Revenues increased by 28% Gross profit increased 43%
https://www.globenewswire.com/news-release/2019/04/10/1802373/0/en/Reviv3-Procare-Company-Reports-Third-Quarter-2019-Financial-Results.html
$RVIV ON ALERT ! @ReviveProcare Reviv3 Procare Company Reports Third Quarter 2019 Financial Results 3rd Quarter Highlights: Revenues increased by 28% Gross profit increased 43%
https://www.globenewswire.com/news-release/2019/04/10/1802373/0/en/Reviv3-Procare-Company-Reports-Third-Quarter-2019-Financial-Results.html
Get to know Vortex Brands Co. $VTXB https://www.smallcapvoice.com/get-to-know-vortex-brands-co/
$BIXT #BreakingNews Bioxytran Inc. Announces Appointment of Ex Bristol-Myers Squibb Executive to Scientific Advisory Board
BOSTON, MASSACHUSETTS, May 06, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), a developmental stage biotechnology company developing a pipeline of anti-necrosis drugs designed to treat hypoxia by delivering a small molecule carrying oxygen to the brain of stroke victims announced today that it has retained Juan Carlos Lopez-Talavera, MD, PhD to join Bioxytran’s Scientific Advisory Board to manage the company’s FDA regulatory application process for Bioxytran’s flagship drug, BXT-25.
“Dr. Lopez-Talavera will play an important role in overseeing our new drug through the FDA’s regulatory process,” stated Bioxytran CEO, David Platt. “Juan has been instrumental in expediting well known drugs such as OCALIVA® through the regulatory process. We believe that Juan’s personal and professional relationships with some of the top pharmaceutical companies and Key Opinion Leaders will bring great value to Bioxytran. His experience in tissue regeneration will bring great skills to our FDA application process and designing our trials for Ischemic Stroke. Bioxytran is truly fortunate to acquire talent of such a high caliber.”
“Dr. Lopez-Talavera has a reputation of developing disruptive technologies which we believe is critical for compounds such as Bioxytran’s BXT-25. It is rare to obtain such a qualified candidate in a developmental stage company like Bioxytran, and we view it as an endorsement of our plans for BXT-25.”
Dr. Lopez-Talavera has over 20 years of experience in the biopharma industry, with extensive expertise in liver and gastrointestinal diseases. Most recently, Dr. Lopez-Talavera was Senior Vice President, Head of Medical Affairs and member of the Executive Team at Intercept Pharmaceuticals. Previously he held positions at AbbVie as Head of Medical Affairs, Global Research and Development, Bristol Myers Squibb, as Vice President and Global Development Lead, and Roche Laboratories as Senior Medical Director. Before moving into the industry, Dr. Lopez-Talavera was an Assistant Professor with the Divisions of Gastroenterology and Hepatology, and Endocrinology and Pathology at the University of Pittsburgh Medical Center, Associate Professor of Medicine with the Universidad Autónoma de Barcelona and Attending Physician of the Liver Unit at the Hospital General Universitari Vall D’Hebron in Barcelona.
“In my professional career I have always gravitated toward working with novel mechanisms. “ said Dr. Lopez-Talavera. ”The opportunity at Bioxytran is so vast, because tissue oxygenation represents a true unmet medical need and represents a tremendous untapped opportunity to target both the Ischemic Stroke and, has future potential for Acute Respiratory Distress Syndrome (“ARDS”). BXT-25 has the unique ability to deliver oxygen through a small molecule which can be effective in extending the “golden hour” in stroke victims and potentially for tissue regeneration in ARDS victims. I am honored to be part of this team and look forward to advancing the science and creating partnerships or joint ventures that will grow this field of research.”
Dr. Lopez-Talavera was a Postdoctoral Fellow at the Yale University School of Medicine, and Clinical Observer at Sloan Kettering Memorial Cancer Center. He holds an M.D. and a Ph.D. in Hepatology from the Universidad Autónoma de Barcelona.
About Bioxytran, Inc.
Bioxytran Inc. is a developmental stage biotechnology company. The company is working towards a first-in-class oxygen treatment platform for victims of brain stroke trauma. The first product to proceed to testing is BXT-25, which will be evaluated as a resuscitative agent to treat strokes, especially during the all-critical first hour following a stroke. The product will also be evaluated for its efficacy in treating other brain trauma issues. BXT-25 is based on a new molecule designed to reverse hypoxia in the brain. Hypoxic brain injuries such as ischemic strokes, could be treated with BXT-25 via an intravenous injection that quickly allows the drug molecule to travel to the lungs and bind with the oxygen molecules. From the lungs the molecule mimics a red blood cell traveling to the brain. Since the molecule is 5,000 times smaller than red blood cells it can penetrate the clot and deliver the oxygen to the critical areas in the brain blocked by the clot. To learn more, visit our website: http://www.Bioxytraninc.com
$ADHC Forms CBD Joint Venture With Hi-Tunes Distribution To Establish A Vertically Aligned CBD/Hemp Firm
DEL MAR, CA / ACCESSWIRE / April 15, 2019 / American Diversified Holdings Corporation (OTC PINK: ADHC) announced that ADHC has established a joint venture partnership to launch a flagship Cannabis / Music culture retail store in Las Vegas, NV. The Las Vegas store is a twist on CBD/HEMP retail store combined with a performance stage and VIP area that will feature live celebrity guests. The store is set to open in July 2019. More information will follow soon.
ADHC has partnered with Hi-Tunes Distribution, Arlington, Wa. https://www.hi-tunes.com/ to provide services to help launch a celebrity line of CBD/Hemp products to be sold at a Las Vegas retail store. Hi-Tunes Distribution is slated to create 40,000 CBD Vape cartridge packages. The packages will be produced to highlight and support musicians. The cartridge packaging will utilize state of the art virtual and augmented reality to distribute new music and videos directly into the hands of the consumer.
https://www.respectmyregion.com/hi-tunes-connecting-music-cannabis/
Additionally,
ADHC has secured various joint venture contracts to convert a high quality CBD/hemp Biomass into vape cartridges to be packaged by Hi-tunes Distribution. All biomass will be sourced directly from Oregon state farms. The biomass will be processed into high grade full spectrum CBD/Hemp Extractd. All products that will grown and produced by licensed ODA (Oregon Department of Agriculture) approved farms and facilities. All CBD/Hemp products shall be grown, processed and produced in accordance with federally established guidelines of the 2018 Farm Bill.
For more information
Contact Liam Riley, COO of ADHC at BloomBergEdelson@gmail.com
This press release contains forward-looking statements pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements include risks and uncertainties that may cause the Company's plans to change and are in no way intended to guarantee that the Company will be successful in executing its plans. Common stock currently trades on the over-the-counter under the symbol ADHC. This press release in no way constitutes any recommendation regarding the securities of ADHC or its affiliates. Any person reading this press release is advised that this release should be considered in the light of all facts and circumstances regarding the business and financial condition and prospects of ADHC, and no reference has been made that this release contains all information.
CONTACT:
ADHCinvestor@gmail.com
Tel: 858-259-4534
SOURCE: American Diversified Holdings Corporation
View source version on accesswire.com:
https://www.accesswire.com/541973/ADHC-Forms-CBD-Joint-Venture-With-Hi-Tunes-Distribution-To-Establish-A-Vertically-Aligned-CBDHemp-Firm
$BOXS News : BoxScore Brands Management Announces Distribution Deal with Pellequr LLC. https://finance.yahoo.com/news/boxscore-brands-management-announces-distribution-205618319.html
Get to know Vortex Brands Co. $VTXB https://www.smallcapvoice.com/get-to-know-vortex-brands-co/
$CETX ON ALERT @Cemtrex Announces NASDAQ and Henry Schein as Latest SmartDesk Customers
Long Island City, NY, April 09, 2019 (GLOBE NEWSWIRE) -- - Cemtrex Inc. (Nasdaq: CETX, CETXP, CETXW), a leading global technology company, today announced that it has added NASDAQ, Inc. and Henry Schein, Inc as its latest SmartDesk Enterprise clients. Both companies have bought SmartDesks to evaluate the product for widescale use in their organizations.
NASDAQ is one the world’s most recognized companies, operating many of the world’s stock market exchanges, with over 4500 employees globally. Henry Schein is a global Fortune 500 healthcare products company with over 18,000 employees globally.
“We continue to see new interest from major enterprises in our SmartDesk as organizations look to create cutting edge workplaces. Both NASDAQ and Henry Schein represent attractive new clients for the SmartDesk with the potential for strong long term demand,” said Saagar Govil, CEO and Chairman of Cemtrex, Inc.
The Company has received demand for SmartDesks from customers in a variety of different industries and for planned uses in different applications. The Company continues to receive orders for use in financial companies, logistics companies, call centers, innovation labs, universities, engineering firms, advertising firms, software developers, and many more.
Cemtrex’s SmartDesk is poised to be the most advanced workstation on the market. A blend of futuristic hardware and groundbreaking productivity software, the SmartDesk delivers an efficient user experience in a luxurious package. With a 72-inch, high resolution multi-touch display, integrated proprietary touch and touchless gestures as well as the ability to draw and scan documents directly on the desk, wireless connectivity for full access to the cloud, and next-generation wireless charging capabilities for mobile devices, the SmartDesk is the next step in the evolution of the modern workplace.
To learn more and stay updated about SmartDesk, please visit www.smartestdesk.com.
About Cemtrex
Cemtrex, Inc. (CETX) is the manufacturer of the SmartDesk, the world’s most advanced workstation. Cemtrex is a diversified technology company that's driving innovation in a wide range of sectors, including smart technology, virtual and augmented realities, advanced electronic systems, industrial solutions, and intelligent security systems.
www.cemtrex.com
https://finance.yahoo.com/news/cemtrex-announces-nasdaq-henry-schein-124000087.html
$BIXT Bioxytran announces plans to use a revolutionary new device, the MDX Viewer, to measure the effectiveness of BXT-25 in stroke patients
Bioxytran announces plans to use a revolutionary new device, the MDX Viewer, to measure the effectiveness of BXT-25 in stroke patients
BOSTON, MASSACHUSETTS, April 04, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), a developmental stage biotechnology company with a pipeline of anti-necrosis drugs designed to treat hypoxia by delivering a small molecule carrying oxygen to the brain of stroke victims announced today that the Company has entered into a definitive exclusive licensing agreement with MDX Lifesciences, Inc. (MDX). The licensing agreement will allow Bioxytran to continue commercial development of MDX technology and develop new protocols that measure the tissue metabolic state of the brain.
The MDXViewer is the primary testing equipment covered under this licensing agreement. This is a worldwide perpetual license for use of the MDXViewer in conjunction with any compound developed by Bioxytran to measure cellular health. Bioxytran agreed to pay a $500,000 licensing fee contingent upon Bioxytran’s receipt of $3.0 million or more in equity financing under the S-1 registration. Bioxtryan also agreed to reimburse MDX for development costs required to use of the device with BXT-25 or other compounds plus a 20% value added fee.
Bioxytran’s proprietary molecule is BXT-25 and it is designed to transport oxygen through severely blocked arteries to oxygen-deprived tissues. We expect that the BXT-25 molecule at room temperature solution will be 5,000 times smaller than a red blood cell and its miniature size should enable its delivery to oxygenate brain tissue where red blood cells will not go due to strokes.
Subject to financing, the Bioxytran expects to be able to accelerate the Investigational New Drug Application (IND) process to obtain the approval necessary to proceed with the Phase 1 study by the end of 2019. After commencement of the Phase 1 study Bioxytran to complete it within 4 – 6 months and should be able to report data within a couple of months after study completion.
Using advanced medical technology and advanced algorithms the MDX Viewer is positioned to measure mitochondrial activity within the brain cells to determine cell rejuvenation and tissue metabolic state. The system uses up to 10 unique parameters to develop a total metabolic score (TMS) which is representative of brain tissue health.
“This licensing agreement is the cornerstone of our clinical trial development program” said David Platt, PhD, Chief Executive Officer of Bioxytran. “There are no pre-clinical models that mimic the behavior of an ischemic stroke. Without a way to measure efficacy (oxygen that reaches the target tissue) it’s unlikely that any new drugs could be developed that make claims about increasing tissue oxygenation. This is a real game changer, not only for Bioxytran, but also for other drug development company’s designing novel drugs to treat stroke. In a market so large, we believe that the license should place Bioxytran in a strong intellectual property position with a device that received FDA approval in 2007. The drug candidate BXT-25 is designed to deliver oxygen to the blocked area in the brain and MDX Lifesciences’s technology will be refined to measure the level of brain tissue recovery with what we expect will be the highest level of accuracy available in the market."
“When people think of measuring oxygen in the body they think of the device in the hospital called a pulse oximeter, which goes on the finger and measures the oxygen level in the blood by light absorption” said Professor Avraham Mayevsky, the Chief Scientific Officer of MDX. “This is not even remotely what MDX Lifesciences does. The MDXViewer, approved by the FDA in 2007, is the first device of its kind to measure the level of tissue metabolic state by measuring mitochondrial activity in vivo. There is a distinct difference between measuring blood in an artery versus mitochondrial activity in the tissue. The MDXViewer has the ability to tell clinicians that a particular organ tissue in the body is dying because it’s not processing the oxygen through the mitochondria. Our goal is to improve our FDA approved device in order to measure cellular recovery in the brain.”
@frontpagestocks https://finance.yahoo.com/news/bioxytran-licensing-fda-approved-technology-110000211.html
$DSCR Announces Site Survey Update for War Eagle Mountain Mining Plan
https://www.bloomberg.com/press-releases/2019-05-02/dscr-announces-site-survey-update-for-war-eagle-mountain-mining-plan